Antibody Subclass and Glycosylation Shift Following Effective TB Treatment

Antibody Subclass and Glycosylation Shift Following Effective TB Treatment

Show other versions (1)

<jats:p>With an estimated 25% of the global population infected with <jats:italic>Mycobacterium tuberculosis</jats:italic> (<jats:italic>Mtb</jats:italic>), tuberculosis (TB) remains a leading cause of death by infectious diseases. Humoral immunity following TB treatmen...

Full description

Bibliographic Details
Main Authors: Grace, Patricia S, Dolatshahi, Sepideh, Lu, Lenette L, Cain, Adam, Palmieri, Fabrizio, Petrone, Linda, Fortune, Sarah M, Ottenhoff, Tom HM, Lauffenburger, Douglas A, Goletti, Delia, Joosten, Simone A, Alter, Galit
Other Authors: Ragon Institute of MGH, MIT and Harvard
Format: Article
Language:English
Published: Frontiers Media SA 2022
Online Access:https://hdl.handle.net/1721.1/136134.2

Internet

https://hdl.handle.net/1721.1/136134.2

Similar Items